Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Baxter International, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Baxter International, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Peter Nicklin has been named corporate vice president of Baxter World Trade Corp. and president of Baxter Europe, effective October 1, 2006. Mr. Nicklin will be responsible for the company’s European operations, which had revenues totaling more than $3 billion in 2005. He will be based in Zurich, Switzerland, reporting to John J. Greisch, corporate vice president and president of Baxter’s international operations.

“With his significant international experience and outstanding track record within the pharmaceutical and medical device industries, Peter is ideally suited to lead our European organization,” said Mr. Greisch. “His talents in developing businesses and people will help drive continued growth for Baxter across Europe.”

Mr. Nicklin joins the company from Bayer AG where he served as president of the Animal Health Division, board member of Bayer HealthCare AG and regional head of Bayer HealthCare’s business in Asia Pacific. Prior to joining Bayer, he was responsible for the Western and Central European pharmaceutical businesses of Novartis AG. He also held several general and executive management positions for Bristol-Myers Squibb Co. in Europe and Asia.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters